Human acute myeloid leukemia cells with internal tandem duplications in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures

Leukemia

Volumn 13, Issue 7, 1999, Pages 1071-1078

  Rombouts, W J C ^a   Broyl, A ^a   Martens, A C M ^b   Slater, R ^a   Ploemacher, R E ^a,c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Erasmus University ^*  (Netherlands)

Author keywords

AML; Cytokines; Flt3 gene; Tandem duplications

Indexed keywords

FLT3 LIGAND; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR; TYROSINE KINASE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; AUTOPHOSPHORYLATION; CELL CULTURE; CELL PROLIFERATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROMA CELL; TANDEM REPEAT;

EID: 0032807094     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401446     Document Type: Article

References (32)

1. Nicola NA. Hematopoietic growth factors and their receptors. Ann Rev Biochem 1989; 58: 54-77.
2. Löwenberg B, Touw I. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281-292.
3. Rosnet O, Mattei MG, Marchetto S, Birnbaum D. Isolation and chromosomal localization of a novel fms-like tyrosine kinase gene. Genomics 1991; 9: 380-385.
4. Lyman SD, Mames L, Zappone J, Sleath PR, Beckmann MP, Bird T. Characterization of the protein encoded by the flt3 (flk2) receptor like tyrosine kinase gene. Oncogene 1993; 8: 815-822.
5. Agnes F, Shamoon B, Dina C, Rosnet O, Birnbaum D, Galibert F. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III. Gene 1994; 145: 283-288.
6. Zola H, Siderius N, Flego L, Beckman I, Seshardi R. Cytokine receptor expression in leukemic cells. Leukemia Res 1994; 18: 347-355.
7. Dubreuil P, Torres H, Courcoul MA, Birg F, Mannoni P. c-fms expression is a marker of human acute myeloid leukemias. Blood 1988; 72: 1081-1085.
8. Wang C, Curtis JE, Geiseller EN, McCulloch EA, Minden MD. The expression of the proto-oncogene c-kit in the blast cells of acute myeloblastic leukemia. Leukemia 1989; 3: 699-702.
9. Stachini A, Fubini L, Severino A, Sanavio F, Aglietta M, Piacibello W. Expression of type III receptor tyrosine kinases FLT3 and KIT and responses to their ligands by acute myeloid leukemia blasts. Leukemia 1996; 10: 1584-1591.
10. Lisovsky M, Estrov Z, Zhang X, Consoli U, Sanchez-Williams G, Schnell V, Munker R, Goodacre A, Savchenko V, Andreeff M. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax. Blood 1996; 88: 3987-3997.
11. Drexler HG. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Leukemia 1996; 10: 588-599.
12. McKenna HJ, Smith FO, Brasel K, Hirschstein D, Bernstein ID, Williams DE, Lyman SD. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children. Exp Hematol 1996; 24: 378-385.
13. Mathews W, Jordan CT, Wiegand GW, Pardoll D, Lemischka IR. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell enriched populations. Cell 1991; 65: 1143-1152.
14. Rosnet O, Bühring HJ, Marchetto S, Rappold I, Lavagna C, Sainty D, Arnoulet C, Chabannon C, Kanz L, Hannum C, Birnbaum D. Human FLT3/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells. Leukemia 1996; 10: 238-248.
15. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin CI. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells, Proc Natl Acad Sci USA 1994; 91: 459-463.
16. Nakao M, Yokota S, Iwai T, Kaneko H, Horiike S, Kashima K, Sonoda Y, Fujimoto T, Misawa S. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia. Leukemia 1996; 10: 1911-1918.
17. Yokata S, Kiyoi H, Nakao M, Iwai T, Misawa S, Okuda T, Sonoda Y, Abe T, Kashima K, Matsuo Y, Naoe T. Internal tandem duplication of the FLT3 gene is preferentially seem in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines. Leukemia 1997; 11 1605-1609.
18. Horiike S, Yokata S, Nakao M, Iwai T, Sasai Y, Kaneko H, Taniwaki M, Kashima K, Fujii H, Abe T, Misawa S. Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia. Leukemia 1997; 11: 1442-1446.
19. Kiyoi H, Naoe T, Yokata S, Nakao M, Minami S, Kuriyama K, Takeshita A, Saito K, Hasegawa S, Shimodaira S, Tamura J, Shimazaki C, Matsue K, Kobayashi H, Arima N, Suzuki R, Morishita H, Saito H, Ueda R, Ohno R. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia 1997; 11: 1447-1452.
20. Iwai T, Yokata S, Nakao M, Kaneko H, Nakai H, Kashima K, Misawa S. Internal tandem duplication in the juxtatransmembrane domain of the flt3 is not involved in blastic crisis of chronic myeloid leukemia. Leukemia 1997; 11: 1992-1993.
21. Kiyoi H, Towatari M, Yokota S, Hamaguchi M, Ohno R, Saito H, Naoe T. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 1998; 12: 1333-1337.
22. French-American-British (FAB) Cooperative group. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 620-625.
23. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauer E, Bartram CR. The use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
24. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994; 8: 1095-1104.
25. Dong F, Dale DC, Bonilla MA, Freedman M, Fasth A, Neijens HJ, Palmblad J, Briars GL, Carlsson G, Veerman AJ, Weite K, Löwenberg B, Touw IP. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997; 11: 120-125.
26. Dong F, Brynes RK, Tidow N, Welte K, Löwenberg B, Touw IP. Mutations in the gene for granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. New Engl J Med 1995; 333: 487-493.
27. Terpstra W, Ploemacher RE, Prins A, van Lom K, Poulwels K, Wognum AW, Wagemaker G, Löwenberg B, Wielenga JJ. Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood 1996; 88: 1944-1950.
28. Terpstra W, Prins A, Ploemacher RE, Wognum AW, Wagemaker G, Löwenberg B, Wielenga JJ. Long-term leukemia-initiating capacity of a CD34-subpopulation of acute myeloid leukemia. Blood 1996; 87: 2187-2194.
29. Diaz MO, Le Beau MM, Harden A, Rowley JD. Trisomy 8 in human hematologic neoplasia and the c-myc and c-mos oncogenes. Leukemia Res 1985; 9: 1437-1442.
30. Degeorges A, Hoffschir F, Cussenot O, Gauville C, Le Duc A, Dutrillaux B, Calvo F. Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalised PNT1 human prostate epithelial cell line. Int J Cancer 1995; 62: 724-731.
31. Delgado MD, Lerga A, Canelles M, Gomez-Casares MT, Leon T. Differential regulation of Max and role of c-myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 1995; 10: 1659-1665.
32. Eckhardt SG, Dai A, Davidson KK, Forseth BJ, Wahl GM, Von Hoff DD. Induction of differentiation in HL60 cells by the reduction of extrachromosomally amplified c-myc. Proc Natl Acad Sci USA 1994; 91: 6674-6678.